Xiao‐Xi Guo

821 total citations
35 papers, 634 citations indexed

About

Xiao‐Xi Guo is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pathology and Forensic Medicine. According to data from OpenAlex, Xiao‐Xi Guo has authored 35 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Computational Theory and Mathematics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Xiao‐Xi Guo's work include Computational Drug Discovery Methods (9 papers), Melanoma and MAPK Pathways (8 papers) and Receptor Mechanisms and Signaling (8 papers). Xiao‐Xi Guo is often cited by papers focused on Computational Drug Discovery Methods (9 papers), Melanoma and MAPK Pathways (8 papers) and Receptor Mechanisms and Signaling (8 papers). Xiao‐Xi Guo collaborates with scholars based in China, United Kingdom and United States. Xiao‐Xi Guo's co-authors include Tian‐Rui Xu, Su An, Richard J. Ward, Ying Liu, Yuan Qu, Chengxiao Wang, Xiuming Cui, Yang Yang, Qian Hao and Ye Yang and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Carbohydrate Polymers.

In The Last Decade

Xiao‐Xi Guo

32 papers receiving 627 citations

Peers

Xiao‐Xi Guo
Lijun Zhu China
Haiming Ding United States
Jae‐Ho Park South Korea
Chaomei Liu United States
Cindy Yang Hong Kong
Chhanda Bose United States
Anusha Bishayee United States
Xiao‐Xi Guo
Citations per year, relative to Xiao‐Xi Guo Xiao‐Xi Guo (= 1×) peers Michal Lichtenstein

Countries citing papers authored by Xiao‐Xi Guo

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Xi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Xi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Xi Guo more than expected).

Fields of papers citing papers by Xiao‐Xi Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Xi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Xi Guo. The network helps show where Xiao‐Xi Guo may publish in the future.

Co-authorship network of co-authors of Xiao‐Xi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Xi Guo. A scholar is included among the top collaborators of Xiao‐Xi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Xi Guo. Xiao‐Xi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lijing, Yaru Zhao, Liqiao Chen, et al.. (2025). Parishin A alleviates insomnia by regulating hypothalamic-pituitary-adrenal axis homeostasis and directly targeting orexin receptor OX2. European Journal of Pharmacology. 998. 177498–177498. 2 indexed citations
2.
Guo, Xuejun, et al.. (2025). Does rural Households’ financial literacy affect the household portfolio choices in poverty alleviation areas?. Economic Analysis and Policy. 85. 1550–1562.
3.
Zhang, Lijing, M. D. Lan, Hui Chen, et al.. (2024). Activation of the Melatonin Receptor MT 1 by the Natural Product Gastrodin to Promote Sleep. Journal of Pineal Research. 76(8). e70016–e70016. 3 indexed citations
4.
Guo, Xiao‐Xi, et al.. (2023). Misunderstanding in intercultural electronic written communication in Chinese business field. 12(2). 153–166. 1 indexed citations
5.
Guo, Xiao‐Xi, et al.. (2023). Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine. Chinese Journal of Integrative Medicine. 29(7). 644–654. 10 indexed citations
6.
Huang, Ying, Jun Peng, Jiaojiao Yu, et al.. (2021). IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways. Experimental Cell Research. 403(2). 112615–112615. 18 indexed citations
7.
Guo, Xiao‐Xi, et al.. (2021). The Effectiveness of Cooperative Learning to Enhance Oral English Proficiency: A Review & Synthesis. Academy of Entrepreneurship journal. 27.
8.
Yang, Yang, Lijing Zhang, Jiaojiao Yu, et al.. (2021). A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease. Frontiers in Pharmacology. 12. 735876–735876. 10 indexed citations
9.
Liu, Ying, Yuting Shao, Richard J. Ward, et al.. (2021). The C-terminal of the α1b-adreneroceptor is a key determinant for its structure integrity and biological functions. Bioscience Biotechnology and Biochemistry. 85(5). 1128–1139. 3 indexed citations
10.
Yu, Jiaojiao, Lijing Zhang, Jun Peng, et al.. (2021). Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways. Biochemical Pharmacology. 195. 114864–114864. 47 indexed citations
11.
Wang, Chengxiao, Shengnan Liu, Xiao‐Xi Guo, et al.. (2020). A novel acidic polysaccharide from the residue of Panax notoginseng and its hepatoprotective effect on alcoholic liver damage in mice. International Journal of Biological Macromolecules. 149. 1084–1097. 55 indexed citations
12.
Guo, Hui, Ying Huang, Yang Yang, et al.. (2019). Comparative interactome analysis reveals distinct and overlapping properties of Raf family kinases. Biochemical and Biophysical Research Communications. 514(4). 1217–1223. 5 indexed citations
13.
Liu, Ying, Luyao Chen, Hong Zeng, et al.. (2018). Assessing the real-time activation of the cannabinoid CB1 receptor and the associated structural changes using a FRET biosensor. The International Journal of Biochemistry & Cell Biology. 99. 114–124. 9 indexed citations
14.
Guo, Hui, Jun Peng, Ying Huang, et al.. (2018). RUVBL1, a novel C-RAF-binding protein, activates the RAF/MEK/ERK pathway to promote lung cancer tumorigenesis. Biochemical and Biophysical Research Communications. 498(4). 932–939. 17 indexed citations
15.
Guo, Hui, Bing Han, Xumin Zhang, et al.. (2018). Revealing A-Raf functions through its interactome. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1866(8). 849–856. 6 indexed citations
16.
Huang, Ying, Su An, Yang Yang, et al.. (2018). C-RAF function at the genome-wide transcriptome level: A systematic view. Gene. 656. 53–59. 3 indexed citations
17.
Liu, Ying, Su An, Richard J. Ward, et al.. (2016). G protein-coupled receptors as promising cancer targets. Cancer Letters. 376(2). 226–239. 99 indexed citations
18.
An, Su, Yang Yang, Richard J. Ward, et al.. (2015). A-Raf: A new star of the family of raf kinases. Critical Reviews in Biochemistry and Molecular Biology. 50(6). 520–531. 28 indexed citations
19.
Yang, Yang, Shu An, Ying Liu, et al.. (2015). Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014). Expert Opinion on Therapeutic Patents. 26(1). 89–106. 6 indexed citations
20.
Yu, Nan, et al.. (2007). Tetraaquabis[2-(3-benzoylphenyl)propanoato-κO]nickel(II) monohydrate. Acta Crystallographica Section E Structure Reports Online. 63(12). m2883–m2883.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026